Qiagen NVQGEN
Price$42.04Intrinsic value$44.295% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.1B+5.7% YoYTTM through 31 Dec 2025
Net Income $424.9M+408.3% YoYTTM through 31 Dec 2025
Free Cash Flow $453.3MTTM through 31 Dec 2025

Margins

Current
Gross Margin62.2%
EBITDA Margin31.6%
Operating Margin22.3%
Net Margin20.3%

Returns

11.3%ROE
6.8%ROA
9.2%ROIC

Balance Sheet Health

Debt / Equity0.44x
Current Ratio3.90x
Net Debt$555.5M
Cash & Equivalents$839M

Quality Metrics

Altman Z-Score3.64
Piotroski F-Score7 / 9
FCF Margin21.7%
Rule of 4024.2
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.1B
Diluted EPS$1.94TTM
'19'20'21'22'23'24'25
FY2025: $1.94

Dividend

$0.35Per share, FY20260.80%Yield1 yrsStreak

Capital Allocation

Capex Intensity9.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.